v3.26.1
Segment Information - Segment Information (Details) - Ionis Operations [Member] - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Information [Abstract]        
Revenue $ 267,949 $ 452,049 $ 514,042 $ 583,660
Cost of sales 2,563 3,541 5,398 4,904
Drug discovery 29,120 30,255 57,677 57,244
Drug development 103,958 117,689 208,140 230,635
Medical affairs 11,318 7,826 21,307 13,468
Manufacturing and development chemistry 20,639 21,545 40,947 35,826
R&D support 26,974 20,607 49,405 41,159
Selling, general and administrative 130,075 81,081 262,012 148,061
Other segment items [1] 57,948 45,954 76,330 75,750
Net income (loss) $ (114,646) $ 123,551 $ (207,174) $ (23,387)
[1] Other segment items include stock-based compensation expense, investment income, interest expense, gain or loss on investments, other income or expense and income tax expense or benefit.